Mark S Silverberg
Overview
Explore the profile of Mark S Silverberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
213
Citations
16698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ten Bokkel Huinink S, Bak M, Beelen E, Erler N, Silverberg M, Allez M, et al.
Aliment Pharmacol Ther
. 2025 Jan;
61(6):1019-1031.
PMID: 39856782
Background: The impact of prophylactic medication following ileocecal resection (ICR) for Crohn's disease (CD) merits further elucidation. Prophylactic medication following ileocecal resection (ICR) is recommended in patients with Crohn's disease...
2.
Olivera P, Martinez-Lozano H, Leibovitzh H, Xue M, Neustaeter A, Espin-Garcia O, et al.
Gastroenterology
. 2024 Sep;
168(1):99-110.e2.
PMID: 39236898
Background & Aims: Unaffected first-degree relatives (FDRs) from families with ≥2 affected FDRs with Crohn's disease (CD, multiplex families) have a high risk of developing CD, although the underlying mechanisms...
3.
Jairath V, Feagan B, Silverberg M, Danese S, Gionchetti P, Lowenberg M, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
23(2):321-330.e3.
PMID: 39025255
Background & Aims: Vedolizumab is indicated for the treatment of chronic pouchitis in the European Union. We assessed whether vedolizumab induced mucosal healing (MH) and if MH was associated with...
4.
Leibovitzh H, Nayeri S, Borowski K, Hernandez-Rocha C, Lee S, Turpin W, et al.
J Crohns Colitis
. 2024 Jul;
PMID: 38980940
Background: Primary sclerosing cholangitis associated with inflammatory bowel disease (IBD-PSC) carries significant morbidity compared to IBD without PSC. Alterations in microbial composition and bile acid (BA) profiles have been shown...
5.
Hernandez-Rocha C, Turpin W, Borowski K, Stempak J, Sabic K, Gettler K, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
23(4):612-620.e10.
PMID: 38969076
Background & Aims: Investigating the tissue-associated microbiota after surgically induced remission may help to understand the mechanisms initiating intestinal inflammation in Crohn's disease. Methods: Patients with Crohn's disease undergoing ileocolic...
6.
Bak M, Demers K, Hammoudi N, Allez M, Silverberg M, Fuhler G, et al.
Aliment Pharmacol Ther
. 2024 Jun;
60(3):310-326.
PMID: 38887827
Background: Risk stratification for endoscopic post-operative recurrence (ePOR) in Crohn's disease (CD) is required to identify patients who would benefit most from initiation of prophylactic medication and intensive monitoring of...
7.
Bowdish D, Chandran V, Hitchon C, Kaplan G, Avina-Zubieta J, Fortin P, et al.
J Rheumatol
. 2024 Apr;
51(7):721-727.
PMID: 38621797
Objective: To determine how serologic responses to coronavirus disease 2019 (COVID-19) vaccination and infection in immune-mediated inflammatory disease (IMID) are affected by time since last vaccination and other factors. Methods:...
8.
Bak M, Hammoudi N, Allez M, Silverberg M, Schellekens I, Erler N, et al.
Gastrointest Endosc
. 2024 Mar;
100(4):703-709.e4.
PMID: 38462057
Background And Aims: The modified Rutgeerts score (mRS) is widely used for the assessment of endoscopic postoperative recurrence (ePOR) in Crohn's disease (CD) after ileocolic resection to guide therapeutic decisions....
9.
Jairath V, Zou G, Wang Z, Adsul S, Colombel J, DHaens G, et al.
BMJ Open Gastroenterol
. 2024 Feb;
11(1).
PMID: 38336367
Introduction: Symptoms, endoscopy and histology have been proposed as therapeutic targets in ulcerative colitis (UC). Observational studies suggest that the achievement of histologic remission may be associated with a lower...
10.
Olivera P, Silverberg M
J Can Assoc Gastroenterol
. 2024 Feb;
7(1):59-67.
PMID: 38314176
Crohn's disease (CD), a chronic inflammatory condition of the digestive tract, poses significant challenges in terms of disease prognosis and treatment selection. Biomarkers have the potential to predict CD outcomes...